MedTrace Logo

Hamburg TranscathEteR Mitral Valve REplacement RegiStry

NCT04914468 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-06-04

No results posted yet for this study

Summary

The Hamburg TranscathEteR Mitral Valve REplacement RegiStry (HERMES) is a prospective clinical cohort registry aiming to gather follow-up information on short- and long-term outcome of patients with mitral valve disease that undergo transcatheter mitral valve replacement (TMVR) screening. In particular, long-term durability and function of implanted bioprosteses is of utmost interest for both patients and clinicians. Moreover, this study aimes to investigate and compare the different treatment strategies patients undergo after successful or unsuccessful screening for TMVR.

Conditions

  • Mitral Valve Disease

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Sebastian Ludwig, MD · University Heart and Vascular Center Hamburg

  • Edith Lubos, MD · University Heart and Vascular Center Hamburg

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04914468 on ClinicalTrials.gov